99% Savings - Buy Just @1 Rs X
Lamivir SE is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Lamivir SE safe for pregnant women?
Lamivir SE can have harmful effects in pregnant women. If you experience any discomfort after using Lamivir SE, then discontinue the use and take your doctor's advice.
Is the use of Lamivir SE safe during breastfeeding?
Side effects of Lamivir SE for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Lamivir SE on the Kidneys?
Lamivir SE has very mild side effects on the kidneys.
What is the effect of Lamivir SE on the Liver?
Side effects of Lamivir SE rarely affect the liver.
What is the effect of Lamivir SE on the Heart?
Lamivir SE is not harmful for the heart.
Lamivir SE should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lamivir SE unless your doctor advises you to do so -
Is this Lamivir SE habit forming or addictive?
Lamivir SE is not addictive in nature.
Interaction between Food and Lamivir SE
When consumed with certain foods, Lamivir SE may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Lamivir SE
Consult your doctor before consuming alcohol while taking Lamivir SE as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sustiva® (efavirenz)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 481-483
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809-810
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zerit® (stavudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807